Drug Discovery & DevelopmentTaxus Cardium Pharmaceuticals Group Inc. announced that the company’s Excellagen flowable dermal matrix in combination with Orbsen Therapeutics’ mesenchymal stromal stem cell therapy Cyndacel-M has been selected for clinical evaluation in a Phase … …read more &nbs… Continue reading
Son’s successful stem cell transplant best Mother’s Day presentAlabama’s13.comDoctors said her son’s stem cell transplant was a success, curing him of two diseases, Burton’s and Crohn’s. She said that is the best Mother’s Day gift she could have hoped for. “You think your kids are the best gift you can get, but then you get … Continue reading
BioNewsJapan’s RIKEN Center has announced that an appeal by stem cell scientist, Dr Haruko Obokata, found guilty of research misconduct in relation to her claims of converting blood cells to stem cells using an ‘acid bath’, has been rejected. Allegations of …Stem cell scientist won’t withdraw research despite Riken’s recommendationThe Japan Daily PressResearcher won’t retract … Continue reading
TheHealthSitestem–cell-page-upload Researchers have merged stem cell and ‘organ-on-a-chip’ technologies to grow, for the first time, functioning human heart tissue carrying an inherited cardiovascular disease. The research appears to be a big step forward for …Patient’s stem cells used to make ‘heart disease-on-a-chip’Deccan Chronicle all 20 news articles …read more &nbs… Continue reading
R & D MagazineResearchers use modified RNA transfection to correct genetic dysfunction in heart stem cells derived from Barth Harvard Univ. scientists have merged stem cell and “organ-on-a-chip” technologies to grow, for the first time, functioning human heart …Stem cell and ‘organ-on-a-chip’ merger step forward for personalized medsTheHealthSitePatient stem cells used to make ‘heart disease-on-a-chip’ECNmag.comPatient’s … Continue reading
Taxus Cardium’s Excellagen… Continue reading
The Japan Daily PressIn spite of the Riken Institute’s recommendation that stem cell researcher Haruko Obokata retract her paper, she remains committed to stand by her research and has no plans of withdrawing it, according to her lawyer, Hideo Miki. Obokata came under fire …Stem cell scientist’s appeal against misconduct verdict rejectedBioNewsResearcher won’t retract STAP … Continue reading
Deccan ChronicleWashington: In a big step forward for personalised medicine, Harvard scientists have for the first time grown a functioning human heart tissue carrying an inherited cardiovascular disease by merging stem cell and ‘organ-on-a-chip’ technologies. The …Patient stem cells used to make ‘heart disease-on-a-chip’EurekAlert (press release) all 15 news articles …read more &nbs… Continue reading